Rankia España Rankia Argentina Rankia Brasil Rankia Chile Rankia Colombia Rankia Czechia Rankia Deutschland Rankia France Rankia Indonesia Rankia Italia Rankia Magyarország Rankia México Rankia Netherlands Rankia Perú Rankia Polska Rankia Portugal Rankia Romania Rankia Türkiye Rankia United Kingdom Rankia USA
Acceder

Seguimiento de farmas para combatir el Covid-19

124 respuestas
Seguimiento de farmas para combatir el Covid-19
3 suscriptores
Seguimiento de farmas para combatir el Covid-19
Página
5 / 9
#61

Re: Seguimiento de farmas para combatir el Covid-19

ADMA Biologics, Inc. (ADMA)


  3.5168  +0.6768 (+23.831%)  A partir de las 11:36 AM EDT. Mercado abierto.

Rango del dia -3.2100 - 4.2000

Rango de 52 semanas 1.4500 - 5.4840  Volumen  28, 711 992
Media Volumen  2,778,136




#63

Re: Seguimiento de farmas para combatir el Covid-19

Qué miedo. Ojalá sea así o tendremos que alinearnos con los antivacunas :)

Nueva candidata que empezaría FI en septiembre y acabaría FIII en diciembre

http://www.globenewswire.com/news-release/2020/07/31/2071010/0/en/Sanofi-and-GSK-selected-for-Operation-Warp-Speed-to-supply-United-States-government-with-100-million-doses-of-COVID-19-vaccine.html

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#65

Re: Seguimiento de farmas para combatir el Covid-19

  Pricing Covid-19 vaccines too high could backfire on big pharmaceutical companies.
.
 I don’t want to single out Moderna here. It doesn’t have a single successful commercial drug, nor any other Phase 3 candidates; its need to make money off this vaccine is arguably acute. Larger drug companies are different. Yet Pfizer NSE 2.30% Inc.’s CEO recently said that calls for companies not to consider making a profit on their Covid-19 vaccines were “fanatic and radical.” (AstraZeneca NSE 1.51% PLC and Johnson & Johnson have promised a not-for-profit effort on their Covid-19 vaccines, 


 ..

#67

Re: Seguimiento de farmas para combatir el Covid-19

Para mi siguen siendo tulipanes, 
#68

Re: Seguimiento de farmas para combatir el Covid-19

#69

Re: Seguimiento de farmas para combatir el Covid-19

La probable futura del premio nobel de medicina Sarah Gilbert sacará millones de dosis de su vacuna para Septiembre y la comercializará Astrazeneca 
#70

Re: Seguimiento de farmas para combatir el Covid-19

 

Sorrento adds to COVID-19-stoked rally, shares up 24%

 
Aug. 10, 2020 1:56 PM ET|About: Sorrento Therapeutics,... (SRNE)|By: Douglas W. House, SA News Editor 
Sorrento Therapeutics (SRNE +23.6%) is adding to its recent breakout on almost double normal volume. Shares have jumped 159% since Wednesday, July 24, when it announced that it planned to acquire COVID-19 therapy developer SmartPharm Therapeutics. The following Monday, July 29, it announced that it in-licensed rights to a rapid test that detects the presence of the SARS-CoV-2 virus in saliva in as little as 30 minutes.

On Friday, May 15, shares rocketed 158% after the company announced a "cure" for COVID-19. Shares quickly retraced on questions about the veracity of its claim, bottoming at $3.82 on June 4. Investors appeared to have brushed off such concerns since shares are up five-fold since then.
Chairman, CEO and President Henry Li, Ph.D. is, no doubt, pleased with the share appreciation. Last week, the board authorized a 10-year performance award for him based solely on the market cap of the company. He will earn options to purchase up to ~24.9M shares at $17.30 representing a 10% stake in the company if fully exercised. The award vests in 10 equal tranches starting with ~2.5M options if the company's market cap reaches $5B. The 10th and last tranche vests if the company's value hits $35B. Assuming full vestment and no further equity offerings, his total award will be potentially worth ~$3.3B.

#71

Re: Seguimiento de farmas para combatir el Covid-19

Hola.
Que barbaridad, va como un cohete 
#73

Re: Seguimiento de farmas para combatir el Covid-19

Me fío poco o nada...
#74

Re: Seguimiento de farmas para combatir el Covid-19

A ver que laboratorio se lleva el premio gordo, apuesto por los anglosajones
Te puede interesar...
  1. Carteras Crecimiento y Conservador. MARZO 2024.
  2. Wall Street afirma que no hay burbuja. ¿Riesgo tampoco?
Brokers destacados